Is Fidelis Insurance Holdings Ltd. overvalued or undervalued?
As of May 14, 2025, Fidelis Insurance Holdings Ltd. is considered overvalued and risky, with poor financial metrics and underperformance compared to peers and the S&P 500.
As of 14 May 2025, the valuation grade for Fidelis Insurance Holdings Ltd. has moved from expensive to risky, indicating a deteriorating outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.80 and an EV to Sales ratio of 0.53, which are both low compared to industry norms. Additionally, the negative EV to EBITDA of -87.26 and a ROE of -0.44% further underscore the challenges the company faces.In comparison to its peers, Fidelis Insurance Holdings Ltd. has a significantly lower EV to EBITDA ratio than Assurant, Inc. at 49.0468 and Kinsale Capital Group, Inc. at 1766.1332, both of which are in a better valuation position. The recent stock performance shows that while Fidelis gained 1.95% over the past week and 4.41% over the past month, it has underperformed the S&P 500 year-to-date and over the past year, with returns of -2.04% and -0.89%, respectively. This performance further supports the conclusion that the stock is overvalued in its current state.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
